GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in GH Research PLC as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −1 vs. Q2 2022
- Shares held
- 31.6M
- −961.0K (−3.0%) vs. Q2 2022
- Total value
- $367.2M
- +$42.2M (+13.0%) vs. Q2 2022
- New holders
- 3
- 8 more added
- Sold out
- 4
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 20 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 220 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,000 | $12.0K | 0.00% | −4,466−81.7% | Reduced |
| Tortoise Investment Management, LLC | 3,081 | $36.0K | 0.01% | −1,000−24.5% | Reduced |
| Tower Research Capital LLC (TRC) | 3,383 | $39.0K | 0.00% | +2,486+277.1% | Added |
| Exchange Traded Concepts, LLC | 5,075 | $59.0K | 0.00% | +190+3.9% | Added |
| Jefferies Group LLC | 10,000 | $116.2K | 0.00% | +10,000 | New |
| Virtus ETF Advisers LLC | 10,026 | $117.0K | 0.05% | +74+0.7% | Added |
| Millennium Management LLC | 10,111 | $117.0K | 0.00% | +10,111 | New |
| State Street Corp | 10,896 | $127.0K | 0.00% | +10,896 | New |
| PEAK6 Investments LLC | 11,059 | $129.0K | 0.00% | −12,258−52.6% | Reduced |
| BlackRock Inc. | 19,519 | $227.0K | 0.00% | −1,567−7.4% | Reduced |
| AdvisorShares Investments LLC | 30,056 | $349.0K | 0.09% | +5,221+21.0% | Added |
| Barclays PLC | 32,090 | $373.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 46,113 | $535.0K | 0.00% | +810+1.8% | Added |
| DAFNA Capital Management LLC | 52,631 | $612.0K | 0.16% | −2,369−4.3% | Reduced |
| HighVista Strategies LLC | 56,769 | $660.0K | 0.38% | −7,167−11.2% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 125,925 | $1.46M | 0.00% | −33,076−20.8% | Reduced |
| Pura Vida Investments, LLC | 158,327 | $1.84M | 0.28% | −50,200−24.1% | Reduced |
| Point72 Asset Management, L.P. | 202,600 | $2.35M | 0.01% | −28,700−12.4% | Reduced |
| Acuta Capital Partners, LLC | 243,250 | $2.83M | 1.26% | 00.0% | Unchanged |
| Laurion Capital Management LP | 314,930 | $3.66M | 0.10% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 463,600 | $5.39M | 0.07% | −18,209−3.8% | Reduced |
| Morgan Stanley | 489,336 | $5.69M | 0.00% | +10,717+2.2% | Added |
| Deep Track Capital, LP | 499,400 | $5.80M | 0.29% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 593,043 | $6.89M | 0.48% | −15,080−2.5% | Reduced |
| Verition Fund Management LLC | 608,124 | $7.07M | 0.10% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,288,102 | $15.0M | 0.02% | −15,368−1.2% | Reduced |
| OrbiMed Advisors LLC | 1,622,060 | $18.8M | 0.37% | 00.0% | Unchanged |
| RTW Investments, LP | 2,168,957 | $25.2M | 0.58% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,333,154 | $38.7M | 5.98% | +147,581+4.6% | Added |
| Ra Capital Management, L.P. | 4,898,373 | $56.9M | 1.21% | 00.0% | Unchanged |
| FMR LLC | 5,012,665 | $58.2M | 0.01% | +75,469+1.5% | Added |
| BVF Inc | 9,275,158 | $107.8M | 4.45% | 00.0% | Unchanged |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,013,399−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −21,400−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −10,236−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −80−100.0% | Sold out |